NCT05269355Phase 2, phase 3Terminated

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

Study sponsor: PTC Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-06-17Actual
Enrollment · participants359Actual
Source updated2025-06-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview